Enlivex Therapeutics Ltd. (ENLV.TA)
ILA 357.1
(5.81%)
ILA 357.1
(5.81%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 36.83 Million USD | -45.55% |
| 2022 | 67.64 Million USD | -28.91% |
| 2021 | 95.14 Million USD | 135.75% |
| 2020 | 40.35 Million USD | 129.83% |
| 2019 | 17.56 Million USD | 59.14% |
| 2018 | 11.03 Million USD | 204.64% |
| 2017 | 3.62 Million USD | -65.93% |
| 2016 | 10.63 Million USD | -48.19% |
| 2015 | 20.51 Million USD | -37.74% |
| 2014 | 32.95 Million USD | 479.56% |
| 2013 | 5.68 Million USD | 3544.87% |
| 2012 | 156 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 31.9 Million USD | 2.75% |
| 2024 Q1 | 31.04 Million USD | -15.7% |
| 2023 FY | 36.83 Million USD | -45.55% |
| 2023 Q1 | 60.02 Million USD | -11.27% |
| 2023 Q4 | 36.83 Million USD | -21.53% |
| 2023 Q3 | 46.93 Million USD | -11.49% |
| 2023 Q2 | 53.02 Million USD | -11.65% |
| 2022 Q3 | 72.41 Million USD | -6.37% |
| 2022 Q4 | 67.64 Million USD | -6.59% |
| 2022 FY | 67.64 Million USD | -28.91% |
| 2022 Q1 | 88.62 Million USD | -6.86% |
| 2022 Q2 | 77.34 Million USD | -12.73% |
| 2021 Q2 | 95.18 Million USD | -0.81% |
| 2021 FY | 95.14 Million USD | 135.75% |
| 2021 Q1 | 95.96 Million USD | 137.78% |
| 2021 Q4 | 95.14 Million USD | -3.08% |
| 2021 Q3 | 98.16 Million USD | 3.13% |
| 2020 Q2 | 35.43 Million USD | -5.88% |
| 2020 FY | 40.35 Million USD | 129.83% |
| 2020 Q3 | 33.37 Million USD | -5.83% |
| 2020 Q4 | 40.35 Million USD | 20.93% |
| 2020 Q1 | 37.65 Million USD | 114.41% |
| 2019 Q3 | 19.21 Million USD | -7.74% |
| 2019 FY | 17.56 Million USD | 59.14% |
| 2019 Q4 | 17.56 Million USD | -8.62% |
| 2019 Q2 | 20.82 Million USD | 9.36% |
| 2019 Q1 | 19.04 Million USD | 72.61% |
| 2018 Q2 | 1.7 Million USD | 0.0% |
| 2018 Q3 | 12.13 Million USD | 611.85% |
| 2018 Q4 | 11.03 Million USD | -9.04% |
| 2018 FY | 11.03 Million USD | 204.64% |
| 2018 Q1 | - USD | -100.0% |
| 2017 FY | 3.62 Million USD | -65.93% |
| 2017 Q3 | 4.28 Million USD | -22.32% |
| 2017 Q4 | 3.62 Million USD | -15.43% |
| 2017 Q1 | 7.88 Million USD | -25.81% |
| 2017 Q2 | 5.51 Million USD | -30.08% |
| 2016 Q3 | 13.37 Million USD | -21.14% |
| 2016 Q2 | 16.95 Million USD | -24.57% |
| 2016 Q1 | 22.47 Million USD | 9.57% |
| 2016 FY | 10.63 Million USD | -48.19% |
| 2016 Q4 | 10.63 Million USD | -20.49% |
| 2015 Q3 | 23.92 Million USD | -11.07% |
| 2015 Q4 | 20.51 Million USD | -14.23% |
| 2015 FY | 20.51 Million USD | -37.74% |
| 2015 Q2 | 26.89 Million USD | -9.88% |
| 2015 Q1 | 29.84 Million USD | -9.43% |
| 2014 Q4 | 32.95 Million USD | -4.59% |
| 2014 Q3 | 34.54 Million USD | 664.84% |
| 2014 Q2 | 4.51 Million USD | 0.0% |
| 2014 FY | 32.95 Million USD | 479.56% |
| 2013 Q4 | 5.68 Million USD | 0.0% |
| 2013 FY | 5.68 Million USD | 3544.87% |
| 2012 FY | 156 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Matricelf Ltd | 39.49 Million ILA | 6.743% |